Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Rigas Austrumu kliniska universitates slimnica SIA

Latvia Hipokrata Iela 4, 1079 Riga, Latvia

About the sponsor

The clinical research activity is centered on cutaneous malignant melanoma, with a focus on patients requiring treatment after radical surgery for higher-risk disease.

  • Adjuvant immunotherapy in melanoma
  • Stage IIb-c, stage III, and stage IV disease
  • Postoperative cancer treatment

Research interest is directed toward treatment strategies for advanced-risk melanoma in the Latvian Oncology Center setting.

About Specializations

Rigas Austrumu kliniska universitates slimnica SIA runs clinical trials in conditions such as Malignant melanoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.